期刊文献+

糖基化白蛋白及超敏C-反应蛋白在2型糖尿病合并冠心病中的作用

Role of glycated albumin and high-sensitivity C-reactive protein in patients with coronary heart disease and type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨糖基化白蛋白(GA)和超敏C-反应蛋白(Hs-CRP)在2型糖尿病合并冠心病患者中的作用。方法选择284例糖尿病患者行冠状动脉(冠脉)造影检查,其中211例为糖尿病合并冠心病且至少1支血管狭窄≥70%组,选择73例单纯糖尿病患者作为对照组,比较2组患者GA及Hs-CRP的变化水平。结果糖尿病合并冠心病组GA和Hs-CRP显著升高[GA为(21.23±0.35)%与(18.94±0.49)%,Hs-CRP为(17.30±1.02)mmol/L与(8.57±0.90)mmol/L](P<0.05);随冠脉病变血管支数增加,GA显著增高,Hs-CRP无明显变化(P>0.05)。结论 GA和Hs-CRP在糖尿病合并冠心病患者发病中具有重要作用。 Objective To explore the influence of glycated albumin (GA) and high- sensitivity C -reactive protein(HsCRP) levels on patients with coronary heart disease and type 2 diabetes mellitus. Methods 284 cases of type 2 diabetes mellitus with coronary angiography (CAM) were included in the study ,211 diabetes mellitus with coronary heart disease which at least one vascular stenosis ≥ 70% as experimental group ( Group I) ,and 73 patients with pure diabetes were served as a control group ( Group II). The changes of the levels of glycated albumin and C - reactive protein in the 2 groups was compared. Serum levels of Serum GA levels were determined with an improved bromocresol purple method, and HsCRP was determined using high - sensitivity ELISA. Results GA and HsCRP levels were significantly higher in Group I than the control group. GA: (21. 23 ± 0. 35) % vs. (18. 94 ± 0. 49)% and HsCRP: ( 17.30 ± 1.02 ) mmol/L vs. ( 8.57 ± 0.90) mmol/L ( P 〈 0.05 ). GA was significantly increased with the number increases of coronary arteries (P 〉 0.05), but was not related to HsCRP level. Conclusion GA and HsCRP may play an important role in the development of coronary heart disease in patients with type 2 diabetes.
出处 《宁夏医学杂志》 CAS 2016年第1期16-18,共3页 Ningxia Medical Journal
关键词 糖基化白蛋白 超敏C-反应蛋白 2型糖尿病 心血管造影 Glycated albumin ,High- sensitivity C- reactive protein Type 2 Diabetes meUitus Angiography
  • 相关文献

参考文献9

  • 1Selvin E,Rawlings AM,Lutsey PL,et al. Fructosamine and glycated al-bumin and the risk of cardiovascular outcomes and death[ J]. Circula-tion ,2015 ,132(4) :269 -277.
  • 2Yang ZK,Sheri Y,Shen WF,et ai. Elevated glycated albumin and re-duced endogenous secretory receptor for advanced glycation endprod-ucts levels in serum predict major adverse cardio — cerebral events inpatients with type 2 diabetes and stable coronaryartery disease [ J ]. In-ternational Journal of Cardiology ,2015,15( 197) :241 - 247.
  • 3Gavin JR. New classification and diagnostic criteria for diabetes melli-tus[ J]. Clinical Cornerstone, 1998 ,1 ( 3 ) : 1 - 12.
  • 4Yin Jianjun,Jin Daoqun,Wang Hong. Serum glycated albumin is supe-rior to hemoglobin Ale for correlating with HMGB1 in coronary arterydisease with type 2 diabetic mellitus patients [ J ]. International Journalof Clinical and Experimental Medicine,2015 ,8(4) :4821 -4825.
  • 5Raghav A,Ahmad J. Glycated serum albumin: a potential diseasemarker and an intermediate index of diabetes control [ J ]. Diabetes& Metabolic Syndrome ,2014,8(4) :245 -251.
  • 6蒲里津,陆林,沈卫峰,张奇,张瑞岩,陈秋静.冠心病患者糖基化白蛋白与肿瘤坏死因子-α水平的关系[J].微循环学杂志,2008,18(4):46-48. 被引量:3
  • 7陆林,蒲里津,张奇,张瑞岩,胡健,杨震坤,吕安康,丁风华,沈杰,陈秋静,沈卫峰.2型糖尿病患者血清糖化白蛋白水平与冠状动脉病变程度的关系[J].中国循环杂志,2007,22(5):343-346. 被引量:11
  • 8王青雷.血清尿酸及超敏C-反应蛋白水平与冠心病严重程度的相关性研究[J].中西医结合心血管病电子杂志,2015,3(4):191-192. 被引量:6
  • 9Tani S,Nagao Ken, Hirayama A. Association of systemic inflamma-tion with the serum apolipoprotein A - 1 level : a cross — sectionalpilot study[ J]. Journal of Cardiology ,2015,24(4) :482 -485.

二级参考文献26

  • 1Jandeleit-Dahm KA, Lassila M, Allen TJ. Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies. Ann N Y Acad Sci, 2005, 1043 (6) :759-766.
  • 2Ramasamy R, Vannucci SJ, Yan SS, et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology, 2005, 15 (7) :16R-28R.
  • 3Kishikawa H, Mine S, Kawahara C, et al. Glycated albumin and cross-linking of CD44 induce scavenger receptor expression and uptake of oxidized LDL in human monocytes. Biochem Biophys Res Commun, 2006, 339(3):846-851.
  • 4Rashid G, Benchetrit S, Fishman D, et al. Effect of advanced glycation end products on gene expression and synthesis of TNF- alpha and endothelial nitric oxide synthase by endothelial cells.Kidney Int, 2004, 66(3):1 099-1 106.
  • 5Jandeleit-Dahm KA, Lassila M, Allen TJ. Advanced glycation end products in diabetes-associated atherosclerosis and renal disease:interventional studies. Ann N Y Acad Sci, 2005, 1043 (6):759-766.
  • 6Gillery P. Oxidative stress and protein glycation in diabetes mellitus. Ann Biol Clin, 2006, 64(4):309-314.
  • 7Mentink CJ, Kilhovd BK, Rondas Colbers GJ, et al . Time course of specific AGEs during optimised glycaemic control in type 2 diabetes. Neth J Med, 2006, 64(1):10-16.
  • 8Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol, 2006, 26(5):1 156-1 162.
  • 9Tan KC,Chow WS,Ai VH,et al.Advanced glycation end products and endothelial dysfunction in type 2 diabetes.Diabetes Care,2002,5:1055-1059.
  • 10Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414:813-820.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部